AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Joohyuk Sohn

Joohyuk Sohn

Yonsei University - Seoul / South Korea
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4962165
연세대학교
person_outline Joohyuk Sohn's MOST POPULAR ARTICLES
1-) Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer New England Journal of Medicine 387 (1), 9-20, 2022
2-) Trastuzumab deruxtecan in previously treated HER2-positive breast cancer New England Journal of Medicine 382 (7), 610-621, 2020
3-) MONARCH 3: abemaciclib as initial therapy for advanced breast cancer Journal of Clinical Oncology 35 (32), 3638-3646, 2017
4-) MONARCH 2: abemaciclib in combination with fulvestrant in women with HR+/HER2− advanced breast cancer who had progressed while receiving endocrine therapy Journal of clinical oncology 35 (25), 2875-2884, 2017
5-) Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial The Lancet 379 (9816), 633-640, 2012